BioMar revealed solid growth across markets for Q3 2021 with a significant increase in volumes and revenue. However, the bottom-line results were affected by global increases in raw material prices, logistic costs and energy prices.
During the pandemic, BioMar managed to grow commercial relationships across the divisions through strong collaboration with customers by building new feed concepts and commercial opportunities. The commercial success is being emphasized by the quarterly results for Q3 2021, where the volume sales grew by 11% year-on-year and reported revenue was up by 17%.
“Looking at the world around us, we are now in the middle of a situation that is completely changing factors of our industry’s cost structure in a way and at a speed that we have not seen before. Throughout the pandemic, it has been difficult to conduct business, but our business model is founded upon a belief in local agility and empowerment of our business units which has enabled us to find strong commercial paths together with our customers. Now that the game is changing completely, we need, as an industry, to find solutions on how to overcome this volatility,” explained Carlos Díaz, CEO BioMar Group.
“The current situation of high prices of raw materials, freight and energy is unfortunately not expected to improve over the next few months and the general supply situation is expected to remain challenging. While it will affect our earnings in the short term, we will make it a priority to be able to ship goods continually to customers worldwide as we play an important role in the supply chain,” concluded Díaz
The EBITDA for the quarter fell from DKK326 million ($50.3 million) in Q3 2020 to DKK282 million ($43.5 million) in Q3 2021 for the consolidated companies, while the non-consolidated joint ventures and associates are recognized in the Q3 2021 consolidated financial statements at a DKK36 million ($5.5 million) share of profit after tax, compared with a DKK44 million ($6.8 million) share of loss in the Q3 2020 period. The significant improvement was generally attributable to Salmones Austral in Chile, as settlement prices on farmed salmon are now improving strongly in that market from a low point caused by the coronavirus pandemic.
Against this background, BioMar has lowered its 2021 EBITDA guidance to the DKK 890–920 million ($137–141 million) range from the previous estimate of DKK 940–985 million ($144–152 million).
